Straight out yesterday’s press release from Valeant Pharmaceuticals:
Valeant Pharmaceuticals International (NYSE
“There is still a significant unmet need in treating one of
Hat tip to The Drug Update and Drug War Rant. Drug War Rant adds “excuse me while I go bang my head against a wall,” by which I take him to mean that it is truly bizarre to see approval being issued for new drugs based on chemical analogues to marijuana less than a month after the FDA denied that (smoked) marijuana has any medical value.